The Post Roll: Value Case for Trulieve (TRUL) & Toxic Pot Stocks
After the coronavirus market carnage Grizzle examines the value case for investing in Trulieve and whether cannabis drinks...
ACB.TO
Pot Stocks Post-Roll – Aurora (ACB), Valens (VLNS) & MediPharm (LABS)
This week Scott Willis and Thomas George discuss the likelihood of a short squeeze on Aurora, which cannabis oil stock to own, Valens or MediPharm + more.
Is Aurora Cannabis Headed for a Technical Bankruptcy?
With a huge writedown likely in the next two months, can Aurora avoid a technical bankruptcy and a cratering stock price?
Aurora Signals Mayday as Chief Promotional Officer Cam Battley Resigns
Aurora Cannabis (TSE: ACB) annouced the resignation of Chief Corporate Officer Cam Battley, with no rationale given investors are left to assume the worst.
Pot Stocks: When the Bubble Bellwether Is a Fugly Duckling
Canopy Growth's earnings show that the potstocks bellweather is no longer leading the pack. We look at the new reality in marijuana stocks.
Aurora Cannabis Q3 2019 Earnings Review – Holding Pattern Continues
Aurora (TSX: ACB) reported Q3 earnings and showed growth in revenue, gross profit while decreasing costs. However, concerns remain with their cash balance.
All Time Highs (Episode 10) Aurora/Canopy Earnings and Aphria Special Committee
This week, the President of Grizzle – Thomas George – discusses Aurora (ACB) and Canopy (WEED) latest earnings as well as the conclusions from Aphria's (APHA) special committee investigation.
Significant Value Remains in Aphria: The Upside vs. Cannabis Peers
We look at the upside remaining for Aphria shares on a relative value basis and as a very...
All Time Highs (Episode 8) Grit Camp and Aurora’s Debt Offering
This week, Thomas George discusses Grit Capital's conference and Aurora Cannabis' convertible debt deal and acquisition of Whistler Medical...